| Aggregate Evidence Quality . | Grade C . |
|---|---|
| Benefits | Early detection of HTN; prevention of CV morbidity in predisposed children and adolescents; identification of secondary causes of HTN |
| Risks, harm, cost | Overtesting, misclassification, unnecessary treatment, discomfort from BP measurement, time involved in taking BP |
| Benefit–harm assessment | Benefits of repeated BP measurement exceeds potential harm |
| Intentional vagueness | None |
| Role of patient preferences | Families may have varying levels of concern about elevated BP readings and may request evaluation on a different time line |
| Exclusions | None |
| Strength | Moderate recommendation |
| Key references | 8,84,85 |
| Aggregate Evidence Quality . | Grade C . |
|---|---|
| Benefits | Early detection of HTN; prevention of CV morbidity in predisposed children and adolescents; identification of secondary causes of HTN |
| Risks, harm, cost | Overtesting, misclassification, unnecessary treatment, discomfort from BP measurement, time involved in taking BP |
| Benefit–harm assessment | Benefits of repeated BP measurement exceeds potential harm |
| Intentional vagueness | None |
| Role of patient preferences | Families may have varying levels of concern about elevated BP readings and may request evaluation on a different time line |
| Exclusions | None |
| Strength | Moderate recommendation |
| Key references | 8,84,85 |